mi pharma ltd Company Information
Group Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
114-116 goodmayes road, ilford, IG3 9UZ
Website
www.pharmami.co.ukmi pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of MI PHARMA LTD at £943.6k based on a Turnover of £2.7m and 0.36x industry multiple (adjusted for size and gross margin).
mi pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of MI PHARMA LTD at £589.1k based on an EBITDA of £134.6k and a 4.38x industry multiple (adjusted for size and gross margin).
mi pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of MI PHARMA LTD at £486.4k based on Net Assets of £217k and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Mi Pharma Ltd Overview
Mi Pharma Ltd is a live company located in ilford, IG3 9UZ with a Companies House number of 08341095. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in December 2012, it's largest shareholder is krishna k. patel with a 100% stake. Mi Pharma Ltd is a established, small sized company, Pomanda has estimated its turnover at £2.7m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Mi Pharma Ltd Health Check
Pomanda's financial health check has awarded Mi Pharma Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
4 Weak
Size
annual sales of £2.7m, make it smaller than the average company (£13.5m)
- Mi Pharma Ltd
£13.5m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Mi Pharma Ltd
- - Industry AVG
Production
with a gross margin of 32.4%, this company has a comparable cost of product (32.4%)
- Mi Pharma Ltd
32.4% - Industry AVG
Profitability
an operating margin of 5.1% make it more profitable than the average company (2.7%)
- Mi Pharma Ltd
2.7% - Industry AVG
Employees
with 18 employees, this is below the industry average (75)
- Mi Pharma Ltd
75 - Industry AVG
Pay Structure
on an average salary of £29.2k, the company has an equivalent pay structure (£29.2k)
- Mi Pharma Ltd
£29.2k - Industry AVG
Efficiency
resulting in sales per employee of £147.5k, this is equally as efficient (£150.4k)
- Mi Pharma Ltd
£150.4k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Mi Pharma Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 133 days, this is slower than average (60 days)
- Mi Pharma Ltd
60 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Mi Pharma Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (14 weeks)
0 weeks - Mi Pharma Ltd
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 87.6%, this is a higher level of debt than the average (59.5%)
87.6% - Mi Pharma Ltd
59.5% - Industry AVG
MI PHARMA LTD financials
Mi Pharma Ltd's latest turnover from December 2023 is estimated at £2.7 million and the company has net assets of £217 thousand. According to their latest financial statements, we estimate that Mi Pharma Ltd has 18 employees and maintains cash reserves of £19.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||
Other Income Or Grants | |||||||||||
Cost Of Sales | |||||||||||
Gross Profit | |||||||||||
Admin Expenses | |||||||||||
Operating Profit | |||||||||||
Interest Payable | |||||||||||
Interest Receivable | |||||||||||
Pre-Tax Profit | |||||||||||
Tax | 0 | ||||||||||
Profit After Tax | 0 | ||||||||||
Dividends Paid | 0 | ||||||||||
Retained Profit | 0 | ||||||||||
Employee Costs | |||||||||||
Number Of Employees | 1 | ||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 1,723,635 | 1,723,635 | 1,723,635 | 1,723,635 | 1,723,635 | 1,723,635 | 1,723,635 | 1,723,635 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 1,723,635 | 1,723,635 | 1,723,635 | 1,723,635 | 1,723,635 | 1,723,635 | 1,723,635 | 1,723,635 | 0 | 0 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,164 | 1,397 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25,726 | 0 | 0 | 0 |
Cash | 19,075 | 13,888 | 6,340 | 19,664 | 14,249 | 7,669 | 26,582 | 23,848 | 114,519 | 42,336 | 33,128 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 3,788 | 0 | 0 | 0 | 0 |
total current assets | 19,075 | 13,888 | 6,340 | 19,664 | 14,249 | 7,669 | 30,370 | 49,574 | 114,519 | 43,500 | 34,525 |
total assets | 1,742,710 | 1,737,523 | 1,729,975 | 1,743,299 | 1,737,884 | 1,731,304 | 1,754,005 | 1,773,209 | 114,519 | 43,500 | 34,525 |
Bank overdraft | 106,020 | 92,220 | 92,220 | 92,232 | 95,388 | 95,388 | 91,200 | 68,485 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 654,846 | 664,842 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35,514 | 33,023 |
Group/Directors Accounts | 0 | 0 | 846,970 | 826,823 | 787,237 | 741,119 | 689,102 | 640,659 | 106,848 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 247,048 | 219,748 | 5,549 | 5,249 | 4,948 | 4,647 | 3,149 | 3,178 | 6,736 | 0 | 0 |
total current liabilities | 1,007,914 | 976,810 | 944,739 | 924,304 | 887,573 | 841,154 | 783,451 | 712,322 | 113,584 | 35,514 | 33,023 |
loans | 367,758 | 596,231 | 669,969 | 745,321 | 815,079 | 884,389 | 956,081 | 1,047,690 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 150,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 517,758 | 596,231 | 669,969 | 745,321 | 815,079 | 884,389 | 956,081 | 1,047,690 | 0 | 0 | 0 |
total liabilities | 1,525,672 | 1,573,041 | 1,614,708 | 1,669,625 | 1,702,652 | 1,725,543 | 1,739,532 | 1,760,012 | 113,584 | 35,514 | 33,023 |
net assets | 217,038 | 164,482 | 115,267 | 73,674 | 35,232 | 5,761 | 14,473 | 13,197 | 935 | 7,986 | 1,502 |
total shareholders funds | 217,038 | 164,482 | 115,267 | 73,674 | 35,232 | 5,761 | 14,473 | 13,197 | 935 | 7,986 | 1,502 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||
Operating Profit | |||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | 0 | ||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 0 | 0 | 0 | 0 | 0 | 0 | -25,726 | 25,726 | -1,164 | -233 | 1,397 |
Creditors | -9,996 | 664,842 | 0 | 0 | 0 | 0 | 0 | 0 | -35,514 | 2,491 | 33,023 |
Accruals and Deferred Income | 27,300 | 214,199 | 300 | 301 | 301 | 1,498 | -29 | -3,558 | 6,736 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||
Investing Activities | |||||||||||
capital expenditure | |||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,723,635 | 0 | 0 | 0 |
cash flow from investments | |||||||||||
Financing Activities | |||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | -846,970 | 20,147 | 39,586 | 46,118 | 52,017 | 48,443 | 533,811 | 106,848 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -228,473 | -73,738 | -75,352 | -69,758 | -69,310 | -71,692 | -91,609 | 1,047,690 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 150,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||
interest | |||||||||||
cash flow from financing | |||||||||||
cash and cash equivalents | |||||||||||
cash | 5,187 | 7,548 | -13,324 | 5,415 | 6,580 | -18,913 | 2,734 | -90,671 | 72,183 | 9,208 | 33,128 |
overdraft | 13,800 | 0 | -12 | -3,156 | 0 | 4,188 | 22,715 | 68,485 | 0 | 0 | 0 |
change in cash | -8,613 | 7,548 | -13,312 | 8,571 | 6,580 | -23,101 | -19,981 | -159,156 | 72,183 | 9,208 | 33,128 |
mi pharma ltd Credit Report and Business Information
Mi Pharma Ltd Competitor Analysis
Perform a competitor analysis for mi pharma ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in IG3 area or any other competitors across 12 key performance metrics.
mi pharma ltd Ownership
MI PHARMA LTD group structure
Mi Pharma Ltd has 1 subsidiary company.
mi pharma ltd directors
Mi Pharma Ltd currently has 1 director, Mrs Krishna Patel serving since Dec 2012.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Krishna Patel | England | 38 years | Dec 2012 | - | Director |
P&L
December 2023turnover
2.7m
+6%
operating profit
134.6k
0%
gross margin
32.5%
-3.32%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
217k
+0.32%
total assets
1.7m
0%
cash
19.1k
+0.37%
net assets
Total assets minus all liabilities
mi pharma ltd company details
company number
08341095
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
December 2012
age
13
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
ASHFORDS PARTNERSHIP LLP
auditor
-
address
114-116 goodmayes road, ilford, IG3 9UZ
Bank
-
Legal Advisor
-
mi pharma ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to mi pharma ltd.
mi pharma ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MI PHARMA LTD. This can take several minutes, an email will notify you when this has completed.
mi pharma ltd Companies House Filings - See Documents
date | description | view/download |
---|